BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19254802)

  • 21. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of Epstein-Barr virus on host gene expression in Burkitt's lymphoma cell lines].
    Broderick P; Hubank M; Sinclair A
    Ai Zheng; 2009 Aug; 28(8):813-21. PubMed ID: 19664326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
    Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
    Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis.
    Lund T; Stokke T; Olsen ØE; Fodstad Ø
    Br J Cancer; 2005 May; 92(9):1773-81. PubMed ID: 15827557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BimL upregulation induced by BCR cross-linking in BL41 Burkitt's lymphoma results from a splicing mechanism of the BimEL mRNA.
    Clybouw C; Hadji A; ElMchichi B; Auffredou MT; Leca G; Vazquez A
    Biochem Biophys Res Commun; 2009 May; 383(1):32-6. PubMed ID: 19332026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle.
    Guo Q; Qian L; Guo L; Shi M; Chen C; Lv X; Yu M; Hu M; Jiang G; Guo N
    Mol Immunol; 2010 May; 47(9):1783-92. PubMed ID: 20338640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
    Nicewonger J; Suck G; Bloch D; Swaminathan S
    J Virol; 2004 Sep; 78(17):9412-22. PubMed ID: 15308735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
    Rao SP; Rechsteiner MP; Berger C; Sigrist JA; Nadal D; Bernasconi M
    Mol Cancer; 2007 Jan; 6():3. PubMed ID: 17214905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.
    Shi M; Gan YJ; Davis TO; Scott RS
    Virus Res; 2013 Oct; 177(1):11-21. PubMed ID: 23891576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
    J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A.
    Shore AM; White PC; Hui RC; Essafi A; Lam EW; Rowe M; Brennan P
    J Virol; 2006 Nov; 80(22):11191-9. PubMed ID: 16943287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis.
    Dehan E; Bassermann F; Guardavaccaro D; Vasiliver-Shamis G; Cohen M; Lowes KN; Dustin M; Huang DC; Taunton J; Pagano M
    Mol Cell; 2009 Jan; 33(1):109-16. PubMed ID: 19150432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.
    Fitzsimmons L; Boyce AJ; Wei W; Chang C; Croom-Carter D; Tierney RJ; Herold MJ; Bell AI; Strasser A; Kelly GL; Rowe M
    Cell Death Differ; 2018 Feb; 25(2):241-254. PubMed ID: 28960205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.